Catalyst Wire Dossier Catalyst Wire Dossier
EMA safety_alert · 2007-03-30

European Medicines Agency recommends restricted use and strengthened warnings for Ketek

View source ↗

Summary

EMA recommends restricted use and stronger warnings for Ketek (telithromycin) due to safety concerns, limiting indications and enhancing risk communication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketek (telithromycin)